RLMD

Relmada Therapeutics Inc (RLMD)

US
$ 0.6451-12.51%

Price Chart

Key Statistics

Market Cap
$ 19.82M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.7M
52W High
$ 4.47
52W Low
$ 0.24
Dividend Yield
0.00%
Beta
0.18

Technicals

50-Day MA
0.3515
200-Day MA
1.5476
52 Week High
4.47
52 Week Low
0.2404

About RLMD

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States.

Employees
17
Headquarters
Coral Gables, FL
CEO
Dr. Sergio Traversa M.B.A., Pharm.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg